ArticleVirus evolution2024
Combined use of pritelivir with acyclovir or foscarnet suppresses evolution of HSV-1 drug resistance.
Hanna Helena Schalkwijk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it